Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2022 | What is Von Hippel-Lindau syndrome?

Ramaprasad Srinivasan • 17 Jun 2022
ASCO 2022
Genitourinary Cancer Kidney Cancer

Ramaprasad Srinivasan, MD, PhD, National Cancer Institute, Bethesda, MD, explains the basics of Von Hippel-Lindau syndrome. This interview took place at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting in Chicago, IL.

More from Ramaprasad Srinivasan

4:12
Kidney cancer at ESMO 2022: KEYNOTE-564 and PROSPER
Ramaprasad Srinivasan • 20 Sep 2022
4:44
Pathophysiology and management of Von Hippel-Lindau syndrome
Ramaprasad Srinivasan • 20 Sep 2022
2:32
Unanswered questions of interest from the LITESPARK-004 trial
Ramaprasad Srinivasan • 20 Sep 2022
9:35
LITESPARK-004: 36 month follow-up of belzutifan in Von Hippel-Lindau syndrome
Ramaprasad Srinivasan • 20 Sep 2022

Related Videos

4:12
PETRA: saruparib in solid tumors with BRCA1/2, PALB2 or RAD51C/D mutations
Timothy Yap • 7 Apr 2024
0:45
SYNC-T combination immunotherapy in mCRPC
George Prendergast • 8 Apr 2024
0:40
PSMA PET findings in 225AC-J591-treated patients with mCRPC
Andres Ricaurte-Fajardo • 9 Apr 2024
0:45
Should radioligand therapies be used in earlier settings in prostate cancer?
Andres Ricaurte-Fajardo • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals